Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON CIPLA BIOCON /
CIPLA
 
P/E (TTM) x 36.2 32.5 111.2% View Chart
P/BV x 4.5 4.0 112.8% View Chart
Dividend Yield % 0.2 0.5 33.3%  

Financials

 BIOCON    CIPLA
EQUITY SHARE DATA
    BIOCON
Mar-22
CIPLA
Mar-22
BIOCON /
CIPLA
5-Yr Chart
Click to enlarge
High Rs4241,083 39.2%   
Low Rs315806 39.1%   
Sales per share (Unadj.) Rs68.2269.7 25.3%  
Earnings per share (Unadj.) Rs8.231.7 25.7%  
Cash flow per share (Unadj.) Rs14.944.8 33.4%  
Dividends per share (Unadj.) Rs0.505.00 10.0%  
Avg Dividend yield %0.10.5 25.6%  
Book value per share (Unadj.) Rs68.5257.8 26.6%  
Shares outstanding (eoy) m1,200.60806.81 148.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.43.5 154.8%   
Avg P/E ratio x45.329.8 152.2%  
P/CF ratio (eoy) x24.721.1 117.3%  
Price / Book Value ratio x5.43.7 147.1%  
Dividend payout %6.115.8 38.9%   
Avg Mkt Cap Rs m443,622762,177 58.2%   
No. of employees `000NANA-   
Total wages/salary Rs m18,80135,299 53.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,840217,633 37.6%  
Other income Rs m6,8913,217 214.2%   
Total revenues Rs m88,731220,851 40.2%   
Gross profit Rs m13,82743,298 31.9%  
Depreciation Rs m8,14210,520 77.4%   
Interest Rs m6761,064 63.6%   
Profit before tax Rs m11,90034,933 34.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1159,338 22.6%   
Profit after tax Rs m9,78525,595 38.2%  
Gross profit margin %16.919.9 84.9%  
Effective tax rate %17.826.7 66.5%   
Net profit margin %12.011.8 101.7%  
BALANCE SHEET DATA
Current assets Rs m83,823147,108 57.0%   
Current liabilities Rs m38,28049,129 77.9%   
Net working cap to sales %55.645.0 123.6%  
Current ratio x2.23.0 73.1%  
Inventory Days Days10163 160.1%  
Debtors Days Days926 1,598.3%  
Net fixed assets Rs m117,184119,415 98.1%   
Share capital Rs m6,0031,614 372.0%   
"Free" reserves Rs m76,281206,364 37.0%   
Net worth Rs m82,284207,977 39.6%   
Long term debt Rs m39,9854,162 960.6%   
Total assets Rs m201,007266,523 75.4%  
Interest coverage x18.633.8 55.0%   
Debt to equity ratio x0.50 2,428.0%  
Sales to assets ratio x0.40.8 49.9%   
Return on assets %5.210.0 52.0%  
Return on equity %11.912.3 96.6%  
Return on capital %10.317.0 60.6%  
Exports to sales %026.2 0.0%   
Imports to sales %7.88.2 95.0%   
Exports (fob) Rs mNA57,094 0.0%   
Imports (cif) Rs m6,36017,803 35.7%   
Fx inflow Rs m8,88560,180 14.8%   
Fx outflow Rs m6,36017,803 35.7%   
Net fx Rs m2,52542,376 6.0%   
CASH FLOW
From Operations Rs m11,76633,259 35.4%  
From Investments Rs m-16,991-18,719 90.8%  
From Financial Activity Rs m2,421-15,998 -15.1%  
Net Cashflow Rs m-2,433-1,323 183.9%  

Share Holding

Indian Promoters % 39.7 13.5 294.5%  
Foreign collaborators % 20.9 20.1 103.9%  
Indian inst/Mut Fund % 24.0 49.0 49.1%  
FIIs % 16.3 27.6 59.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 66.4 59.3%  
Shareholders   341,016 418,910 81.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex Tanks 652 Points, Nifty Ends Below 17,800; IndusInd Bank & Bajaj Finserv Top Losers(Closing)

After opening the day on a flat note, Indian share markets turned volatile during the afternoon session and fell hard as selling was seen in banking and auto stocks.